Fig. 4From: Nuclear HER3 expression improves the prognostic stratification of patients with HER1 positive advanced laryngeal squamous cell carcinomaKaplan–Meier analyses of survival curves as a function of HER family phenotypes in LSCC. Bioradiotherapy with cetuximab (A, B) and upfront surgery with or without postoperative radio/chemo-radiotherapy (C, D) treated patientsBack to article page